SenoMark® Breast Tissue Marker SMEC10GSSRecalls & reported problems
Senorx, Inc. · SENOMARK® Breast Tissue Marker, 10 Ga EnCor, SS "M" · Class 2 · Implant
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 5
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 00801741031915), received between Feb 21, 2018 and May 19, 2022 — classified as 1 injury, 4 malfunctions.
The most frequently reported specific device problem is “Patient-Device Incompatibility” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem2
- Patient-Device Incompatibility2
- Positioning Failure2
- Detachment of Device or Device Component1
- Difficult to Remove1
- Failure to Advance1
- Separation Failure1
Patient problems
- No Consequences Or Impact To Patient3
- Hemorrhage/Blood Loss/Bleeding1
- No Clinical Signs, Symptoms or Conditions1
Recent adverse event reports
The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.
MalfunctionMay 19, 2022Patient-Device Incompatibility; Adverse Event Without Identified Device or Use Problem; Patient-Device Incompatibility; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT POST BREAST MARKER PLACEMENT PROCEDURE, THE PATIENT ALLEGEDLY EXPERIENCED ALLERGY. HOWEVER NO ADDITIONAL INTERVENTION OR MEDICATION PERFORMED TO TREAT THIS ALLERGY. THERE WAS NO REPORTED PATIENT INJURY.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 14446612 ↗InjuryJun 4, 2021Positioning Failure; Adverse Event Without Identified Device or Use Problem; Positioning Failure; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT DURING A BIOPSY PROCEDURE, THE PATIENT HAD EXCESSIVE BLEEDING DUE TO MULTIPLE TIME REMOVAL. THE PROCEDURE WAS COMPLETED USING ANOTHER DEVICE. THE PATIENT'S CURRENT STATUS WAS UNKNOWN.
Patient problems: Hemorrhage/Blood Loss/Bleeding
MAUDE report 11937162 ↗MalfunctionApr 17, 2019Patient-Device Incompatibility; Patient-Device Incompatibility
THIS REPORT SUMMARIZES ONE MALFUNCTION EVENT. A REVIEW OF THE EVENTS INDICATED THAT MODEL SMEC10GSS MARKER ALLEGEDLY EXPERIENCED PATIENT-DEVICE INCOMPATIBILITY. THIS REPORT WAS RECEIVED FROM ONE SOURCES. THE DEVICE WAS USED IN THE PATIENT, A (B)(6) YEAR-OLD FEMALE, OF (B)(6) LBS. THERE WAS NO REPORTED PATIENT INJURY.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 8525439 ↗MalfunctionJun 7, 2018Positioning Failure; Difficult to Remove; Failure to Advance; Positioning Failure; Difficult to Remove; Failure to Advance
IT WAS REPORTED THAT DURING A MAMMOGRAPHIC-GUIDED BREAST BIOPSY FOR A SMALL CLUSTER OF CALCIFICATIONS, THE MARKER ALLEGEDLY FAILED TO ADVANCE, FAILED TO DEPLOY, AND AFTERWARDS FAILED TO BE REMOVED FROM THE PROBE. REPORTEDLY, THE PATIENT WAS GIVEN MORE LOCAL ANESTHESIA (LIDOCAINE) AND THE PROBE AND A PORTION OF THE MARKER WERE REMOVED AS ONE UNIT FROM THE PATIENT, WHILE THE CUTTER WAS OPEN. POST PROCEDURE IMAGING INDICATED THAT A PORTION OF THE MARKER WAS ALLEGEDLY SHEARED OFF BY THE CUTTER AND NOW REMAINS IN THE PATIENT. THERE WAS NO REPORTED PATIENT INJURY.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 7580884 ↗MalfunctionFeb 21, 2018Separation Failure; Detachment of Device or Device Component; Separation Failure; Detachment of Device or Device Component
IT WAS REPORTED THAT POST BREAST TISSUE MARKER PLACEMENT, THE MARKER APPLICATOR TIP WAS NOTED TO HAVE DETACHED. THERE WAS NO REPORTED PATIENT INJURY.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 7287759 ↗
Other MARKER, RADIOGRAPHIC, IMPLANTABLE devices
- BioZorb F0202Hologic, Inc. · MARKER, RADIOGRAPHIC, IMPLANTABLE2 recalls192 reports
- BioZorb F0221Hologic, Inc. · MARKER, RADIOGRAPHIC, IMPLANTABLE3 recalls15 reports
- BioZorb F0203Hologic, Inc. · MARKER, RADIOGRAPHIC, IMPLANTABLE2 recalls51 reports
- BioZorb F0231Hologic, Inc. · MARKER, RADIOGRAPHIC, IMPLANTABLE2 recalls19 reports
- BioZorb F0303Hologic, Inc. · MARKER, RADIOGRAPHIC, IMPLANTABLE2 recalls19 reports
- BioZorb F0304Hologic, Inc. · MARKER, RADIOGRAPHIC, IMPLANTABLE2 recalls19 reports
- BioZorb F0404Hologic, Inc. · MARKER, RADIOGRAPHIC, IMPLANTABLE2 recalls6 reports
- BioZorb F0331Hologic, Inc. · MARKER, RADIOGRAPHIC, IMPLANTABLE2 recalls4 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page